Abstract-Myocardial generation of insulin-like growth factor-1 (IGF-1) is altered in hypertrophy and heart failure, but there are no reports on acute functional effects of IGF-1 in human cardiac muscle. We examined inotropic responses and signal transduction mechanisms of IGF-1 in human myocardium. Experiments were performed in isolated trabeculae or cardiomyocytes from 46 end-stage failing hearts. The effect of IGF-1 (0.001 to 0.2 mol/L) on isometric twitch force (37°C, 1 Hz), intracellular Ca 2ϩ transients (aequorin method), sarcoplasmic reticulum (SR) Ca 2ϩ content (rapid cooling contractures), L-type Ca 2ϩ current (whole-cell voltage clamp), and cAMP concentrations was assessed. In addition, the effects of blocking IGF-1 receptors, phosphoinositide 3-kinase (PI3-kinase), protein kinase C (PKC), or transsarcolemmal Ca 2ϩ entry were tested. IGF-1 exerted concentration-dependent positive inotropic effects (twitch force increased to maximally 133Ϯ4% of baseline values at 0.1 mol/L; PϽ0.05). The IGF-1 receptor antibody ␣IR3 or the PI3-kinase inhibitor wortmannin prevented the functional effects. Key Words: insulin-like growth factor-1 Ⅲ functional effects Ⅲ Ca 2ϩ handling Ⅲ heart failure Ⅲ human myocardium I nsulin-like growth factor-1 (IGF-1), a circulating and locally produced peptide hormone structurally and functionally related to insulin, is synthesized under the control of growth hormone (GH) by various cell types, including cardiac myocytes. 1 IGF-1 stimulates protein synthesis and growth and exerts metabolic as well as antiapoptotic effects in many organs including cardiac muscle. [2] [3] [4] Recently, increased local cardiac IGF-1 release and increased cardiac IGF-1 mRNA production and IGF-1 receptor expression were reported in heart failure animal models and in human cardiac diseases. [5] [6] [7] Normal activation of the GH-IGF axis is essential for myocardial performance, 8 and GH/IGF-1 deficiency is associated with impaired cardiac function. 9 Chronic GH substitution may induce beneficial long-term effects on myocardial function in GH deficiency 8 and chronic heart failure. 10, 11 Interestingly, acute application of IGF-1 also enhanced circulatory function with increased stroke volume and cardiac output in healthy volunteers and patients with chronic heart failure. 12,13 However, IGF-1 exerts endothelium-dependent vasodilatory actions, 14,15 and it remains unclear whether improved hemodynamics result from direct inotropic or peripheral vasodilatory effects of IGF-1.
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nsulin-like growth factor-1 (IGF-1), a circulating and locally produced peptide hormone structurally and functionally related to insulin, is synthesized under the control of growth hormone (GH) by various cell types, including cardiac myocytes. 1 IGF-1 stimulates protein synthesis and growth and exerts metabolic as well as antiapoptotic effects in many organs including cardiac muscle. [2] [3] [4] Recently, increased local cardiac IGF-1 release and increased cardiac IGF-1 mRNA production and IGF-1 receptor expression were reported in heart failure animal models and in human cardiac diseases. [5] [6] [7] Normal activation of the GH-IGF axis is essential for myocardial performance, 8 and GH/IGF-1 deficiency is associated with impaired cardiac function. 9 Chronic GH substitution may induce beneficial long-term effects on myocardial function in GH deficiency 8 and chronic heart failure. 10, 11 Interestingly, acute application of IGF-1 also enhanced circulatory function with increased stroke volume and cardiac output in healthy volunteers and patients with chronic heart failure. 12, 13 However, IGF-1 exerts endothelium-dependent vasodilatory actions, 14, 15 and it remains unclear whether improved hemodynamics result from direct inotropic or peripheral vasodilatory effects of IGF-1.
A limited number of investigations have directly tested the acute functional effects of IGF-1 in mammalian myocardium. In these studies, IGF-1 increased contractility in isolated rat, 16 ferret, 17 or dog 18 myocardium, but the subcellular mechanism of action of IGF-1 remained controversial. 17, 18 No data are available on functional effects of IGF-1 in human cardiac muscle.
Therefore, we directly assessed functional effects and mechanisms of action of IGF-1 in isolated failing human myocardium. Our main finding was that IGF-1 exerts receptor-mediated, Ca 2ϩ -dependent positive inotropic effects that are related to a phosphoinositide 3-kinase (PI3-kinase)-dependent activation of L-type Ca 2ϩ currents and Na ϩ -H
Materials and Methods

Human Myocardium
Experiments were performed in muscle strips obtained from 46 end-stage failing hearts (from 14 female and 32 male patients). The mean ejection fraction before transplantation was 23.4Ϯ0.8%. The study protocol was approved by the local ethics committee. For details, please refer to the expanded Materials and Methods section available in the online data supplement at http://www.circresaha.org.
Muscle Strip Preparation
Small endocardial trabeculae were dissected from the left or right ventricle as previously described, 19 connected to an isometric force transducer, and superfused with bicarbonate-containing Tyrode's solution. Muscles were field stimulated at 1 Hz (37°C), and isometric contractions were recorded at optimal preload (L max ). The functional effects of IGF-1 were assessed by cumulative concentration-response curves (0.001 to 0.2 mol/L) or by a single, maximally effective concentration of IGF-1 (0.1 mol/L).
Aequorin Measurements
At steady-state contractile function, the Ca 2ϩ -regulated bioluminescent photoprotein aequorin was macroinjected into the quiescent muscle as described previously. 19 Aequorin light emission was detected using a photomultiplier, which was vertically mounted with its cathode just above the glass cuvette containing the muscle.
Rapid Cooling Contractures (RCCs)
RCCs were elicited by a rapid decrease in the temperature of the muscle chamber from 37°C to 1°C by switching from a warm to a cold solution with solenoid pinch valves at the bath inlet as previously described. 20 The resulting cooling contracture is an index for sarcoplasmic reticulum (SR) Ca 2ϩ content.
Patch-Clamp Experiments
Human ventricular myocytes were isolated with collagenase. 21 Ca 2ϩ currents were recorded using the whole-cell patch-clamp technique. 22 Myocytes were placed in a 0.5-mL chamber and superfused with Tyrode's solution (30°C). Currents were recorded using a Multiclamp 700 patch-clamp amplifier (Axon Instruments). The peak inward current during a depolarization step from Ϫ40 to ϩ10 mV was taken as I Ca,L . At steady-state basal current recordings, IGF-1 (0.1 mol/L) was added to the superfusate, and the effects of IGF-1 on Ca 2ϩ currents were analyzed.
cAMP Determinations
Intracellular cAMP levels in homogenates of IGF-1-or isoproterenol (ISO)-prestimulated muscle strips were measured by a commercially available [ 3 H]cAMP assay system (Amersham Pharmacia) according to the protocol provided by the manufacturer.
Drugs
Recombinant human IGF-1 (Sigma) or IGF-1 receptor antibody (␣IR-3 clone; Oncogene Research Products) was dissolved in Tyrode's solution and added to the organ bath. Diltiazem (Sigma), HOE642 (Cariporide; a gift of Aventis Pharma), KB-R7943 (Tocris), or wortmannin (Sigma) was added to the organ bath 30 minutes before the experiment.
Statistical Analysis
Data are expressed as meanϮSEM. Differences were compared by paired Student t test or one-way repeated measures ANOVA followed by the Student-Newman-Keuls test when appropriate. Statistical significance was taken as PϽ0.05.
Results
Inotropic Effects of IGF-1
IGF-1 (0.1 mol/L) exerted pronounced positive inotropic effects in isolated human cardiac muscle ( Figure 1A , top panel). The inotropic response developed to a stable plateau phase within 3 to 4 minutes without changes in diastolic tension. These functional effects of IGF-1 were mediated via specific IGF-1 receptors; preincubation of a preparation from the same heart with the specific IGF-1 receptor antibody ␣IR-3 (3.3 g/mL) for 30 minutes prevented the inotropic response to IGF-1 (bottom panel).
The functional effects of IGF-1 were concentration dependent ( Figure 1B) . The inotropic response started at 0.01 mol/L and was maximal at 0.1 mol/L with an increase in twitch tension to 133.4Ϯ4.4% of the baseline value (nϭ11, PϽ0.05). The EC 50 was 0.020 mol/L (95% confidence interval ϭ 0.015 to 0.027 mol/L). Diastolic tension and time parameters of contraction and relaxation were not affected by IGF-1. There were no significant differences in inotropic responses to IGF-1 between trabeculae from hearts with dilated or ischemic cardiomyopathy. As can also be seen from Figure 1B , preincubation of muscle strips with the IGF-1 receptor antibody ␣IR-3 (nϭ7) almost completely prevented the inotropic response to IGF-1.
Subcellular Mechanisms of Action of IGF-1
Further experiments were performed in aequorin-loaded muscle strips and compared with the effects of increasing [Ca 2ϩ ] o mol/L, nϭ6) resulted in a proportional increase in twitch tension and aequorin light emission (by 46Ϯ9% and 51Ϯ12% of the basal value, respectively; PϽ0.05). To further elucidate the IGF-1-dependent signal transduction pathways, wortmannin (0.1 mol/L) was used to block the PI3-kinase in aequorin-loaded muscle strips. Preincubation with wortmannin did not affect basal contractile force or relaxation (Table  1 ), but almost completely prevented both the increase in twitch force and Ca 2ϩ transients after IGF-1 ( Figure 3 , right). Inotropic effects may be brought about by cAMPdependent or cAMP-independent mechanisms. cAMPdependent interventions are usually associated with enhanced relaxation and an overproportional increase in intracellular Ca 2ϩ transients. 23 Table 2 Table 2 ). These experiments suggest that IGF-1 exerts its positive inotropic effect by a cAMPindependent increase in intracellular Ca 2ϩ transients. To support this hypothesis, we directly measured cAMP concentrations in trabeculae under control conditions and after stimulation with IGF-1 or ISO. Under control conditions, cAMP levels were 470Ϯ158 pg/mL and did not increase after preincubation with IGF-1 (616Ϯ126 pg/mL, NS). In contrast, after preincubation with ISO (0.1 mol/L), cAMP concentrations were increased to 1208Ϯ247 pg/mL (PϽ0.05 versus control or IGF-1).
Effects of IGF-1 on SR Ca 2؉ Handling
We performed rapid-cooling experiments to directly assess the effects of IGF-1 on SR Ca 2ϩ content. Figure 4A shows a representative original recording. The upper tracing reflects 
⌬F indicates change in force of contraction; ⌬RT 50 , change in relaxation time to 50% of peak tension; ⌬RT 90 , change in relaxation time to 10% of peak tension; CPA, cyclopiazonic acid; and Rya, ryanodine. *PϽ0.05.
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temperature near the surface of the muscle, and the lower tracing represents twitch force. At steady-state isometric contractions, the muscle was cooled to Ϸ1°C, and a stable cooling contracture as an index for SR Ca 2ϩ content developed. On rewarming, the muscle completely relaxed, and the experimental protocol was repeated after addition of IGF-1. IGF-1 increased both isometric twitch tension and the amplitude of the cooling contracture. The average data are presented in Figure 4B (left). IGF-1 (0.1 mol/L) significantly increased twitch force and RCCs by 38.8Ϯ9.3% and 27.6Ϯ9%, respectively. This indicates that the inotropic effect of IGF-1 is associated with increases in SR Ca 2ϩ content. Then, we blocked SR Ca 2ϩ storage function by preincubating muscle strips with cyclopiazonic acid (20 mol/L) and ryanodine (1 mol/L). This resulted in a significant decline in twitch force (by 42%) and prolongation of relaxation times (Table 1) . However, no RCCs could be elicited under these conditions, and contractions may result exclusively from transsarcolemmal Ca 2ϩ cycling. 20 Interestingly, the inotropic response to IGF-1 was unchanged with a blocked SR; as can be seen from Figure 4B (right), IGF-1 (0.1 mol/L) increased force of contraction by 43.7Ϯ14.2% (PϽ0.05) without detectable RCCs in the presence of cyclopiazonic acid and ryanodine.
In additional experiments, we used paired cooling contractures to test whether IGF-1 directly affected SR Ca 2ϩ uptake. 20 The rationale for these experiments is that during the rewarming period (in the unstimulated muscle), cytosolic Ca 2ϩ is competitively removed from the cytosol by sarcoplasmic/endoplasmic reticulum Ca 2ϩ ATPase 2a and Na ϩ -Ca 2ϩ exchange. The RCC2/RCC1 ratio in failing human trabeculae was 52% in the absence of and 51% in the presence of 0.1 Figure 5A shows typical current recordings during depolarization steps from Ϫ40 to ϩ10 mV. It can be seen that the amplitude of the Ca 2ϩ current increases, while the decay kinetics remain unchanged. Similar experiments were performed in a total of 5 ventricular myocytes ( Figure 5B ). In these experiments, the basal current amplitude induced by the voltage step from Ϫ40 to ϩ10 mV was 2.54Ϯ0.63 nA. IGF-1 (0.1 mol/L) significantly increased I Ca,L amplitude to 124Ϯ7% of the basal value.
In a separate set of experiments in trabeculae, the effects of preincubating muscle strips with the L-type Ca 2ϩ channel antagonist diltiazem (5 mol/L) on the inotropic response to IGF-1 was investigated. At this concentration, diltiazem exerted a pronounced negative inotropic effect (Table 1) . Applied at contractile steady-state conditions, the inotropic response to IGF-1 was significantly reduced in the presence of the Ca 2ϩ channel blocker ( Figure 6 ). These experiments suggest that the increase in intracellular Ca 2ϩ transients and twitch force with IGF-1 are partly mediated by enhanced Ca 2ϩ entry through L-type Ca 2ϩ channels.
Intracellular Ca 2ϩ accumulation may also be modulated by the Na ϩ -Ca 2ϩ exchanger. This electrogenic ion transporter extrudes Ca 2ϩ for Na ϩ influx in its forward mode but may also work in its reverse mode, resulting in Ca 2ϩ influx during depolarization. 24 The latter may be favored by increases in [Na ϩ ] i . Interestingly, recent experiments demonstrated an IGF-1-mediated stimulation of the sarcolemmal Na ϩ -H ϩ exchanger in vascular smooth muscle cells. 25 In the present study, preincubation of muscle strips with the Na ϩ -H ϩ exchange inhibitor HOE642 (3 mol/L) only slightly affected basal force (Table 1 ) but resulted in a significant reduction in the maximal inotropic response to IGF-1 (by 60Ϯ15%; PϽ0.05; Figure 6 ). In a further set of experiments, the effects of the reverse-mode Na ϩ -Ca 2ϩ exchange inhibitor KB-R7943 (5 mol/L) were tested. KB-R7943 exerted a significant depressant effect on basal force of contraction (Table 1) . Applied at steady-state contractile conditions, the positive inotropic effect of IGF-1 was reduced by 70Ϯ9% (PϽ0.05; Figure 6 ) in the presence of KB-R7943. These data indicate that the inotropic response to IGF-1 is related to enhanced transsarcolemmal Ca 2ϩ entry through both L-type Ca 2ϩ channels and reverse-mode Na ϩ -Ca 2ϩ exchange. The latter may be secondary to an IGF-1-mediated activation of the Na ϩ -H ϩ exchanger with subsequent [Na ϩ ] i accumulation. Because both Na ϩ -H ϩ exchange and L-type Ca 2ϩ channels may be activated through protein kinase C (PKC), 26, 27 we preincubated muscle preparations with the PKC inhibitor GF109203X (nϭ4). PKC inhibition did not affect basal contractility (Table 1) , but it resulted in a significant reduction in the inotropic response to IGF-1 by 69Ϯ4% (PϽ0.05).
Discussion
This is the first report on functional effects of IGF-1 in isolated human myocardium. The results show that (1) IGF-1 exerts a concentration-dependent positive inotropic effect that is almost completely prevented by blocking IGF-1 receptors or PI3-kinase, (2) the inotropic effect is related to a cAMPindependent increase in intracellular Ca 2ϩ transients, and (3) IGF-1 increases L-type Ca 2ϩ currents and activates Na ϩ -H ϩ exchange and reverse-mode Na ϩ -Ca 2ϩ exchange.
Acute and Long-Term Effects of IGF-1 in the Cardiovascular System
IGF-1 exerts acute hemodynamic as well as long-term genomic effects in the cardiovascular system. Genomic effects include induction of muscle growth, hypertrophy, and antiapoptotic signaling. 1, 2, 4 Experimental and clinical studies indicate that long-term application of GH or IGF-1 may have beneficial effects in heart failure. 3, 10, 28 In addition, acute application of IGF-1 to human healthy volunteers or to patients with heart failure increases cardiac output, 12, 13 but the underlying mechanisms for these hemodynamic effects remain unclear. Noninvasive studies demonstrated endothelium-dependent vasodilatory actions of IGF-1 in humans, which could account for improved hemodynamics on infusion of IGF-1. 14,15 IGF-1 exerted direct positive inotropic effects in isolated mammalian cardiac muscle, 16 -18 and inotropic effects of IGF-1 could contribute to enhanced 
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circulatory function in humans. However, no data on direct functional effects of IGF-1 in the human heart are available.
Direct Functional Effects of IGF-1 in Isolated Human Myocardium
We observed a Ϸ35% increase in isometric twitch force at 0.1 mol/L IGF-1 without changes in relaxation parameters or diastolic function. This inotropic response to IGF-1 amounts to 30% to 40% of the maximal positive inotropic effects of ␤-adrenoceptor stimulation in failing human myocardium. 29 Therefore, the acute functional effects of IGF-1 are substantial and of potential clinical relevance. The magnitude of the inotropic responses to IGF-1 in this study is comparable to the effects previously reported in isolated neonatal 16 and adult 30 rat myocytes, canine myocytes, 18 and ferret trabeculae. 17 The inotropic response to IGF-1 in the present study started at a concentration of 0.01 mol/L (75.8 ng/mL) and was maximal at a concentration of 0.1 mol/L (758 ng/mL). These concentrations are identical to those in isolated ferret muscle 17 and comparable to experiments in isolated rat and dog myocytes. 19, 29 In humans, IGF-1 plasma levels do not reach such high values. 31 However, increases in local cardiac IGF-1 peptide content and upregulation of IGF-1 receptors as well as increased local cardiac IGF-1 release have been observed in myocardium from animal models of pressure or volume overload or ischemic cardiomyopathy. 5, 7 In addition, myocardial hypertrophy was associated with a cardiacspecific increase in IGF-1 mRNA expression and peptide generation. 6 Therefore, IGF-1 exerts its effects on cardiac myocytes not only in an endocrine but also an autocrine/ paracrine fashion within the heart, and IGF-1 concentrations at the level of the myocytes may be substantially higher than in the systemic circulation.
Signal Transduction Pathways of IGF-1 in Human Myocardium
IGF-1 may bind to both types of IGF receptors and to insulin receptors, but the IGF-1 receptor, a heterotetrameric protein with intrinsic tyrosine kinase activity, is most abundant in adult myocardium. 31, 32 In the present study, IGF-1 effects were almost completely prevented by preincubation with the selective IGF-1 receptor antibody ␣IR-3. This demonstrates the role of specific IGF receptors of the subtype 1 in the functional effects of IGF-1 in human myocardium.
Activation of several signal transduction pathways after IGF-1 receptor stimulation were described. 33 One of these pathways involves phosphorylation of insulin-receptor substrate with consecutive activation of PI3-kinase. 1 The PI3-kinase-dependent pathway mediates antiapoptotic signaling and trophic effects via activation of Akt, a serine/threonine protein kinase, 34 and promotes glycogen synthesis through phosphorylation of glycogen synthase kinase 3. 34 In the present study, preincubation of human ventricular muscle with the selective PI3-kinase inhibitor wortmannin prevented the IGF-1-dependent inotropic effect and the increase in Ca 2ϩ transients. This demonstrates that PI3-kinase activation is a key event in the signal transduction network ultimately resulting in functional effects. The involvement of PI3-kinase activation in the inotropic response to IGF-1 is consistent with a previous report in rat heart. 18 On the other hand, PI3-kinase inhibition was described to modify ␤ 2 -adrenoceptor signaling in adult rat myocardium enabling ␤ 2 -adrenoceptors to induce phospholamban phosphorylation and increase contractility and Ca 2ϩ transients. 35 This finding may point to distinct pathways of PI3-kinase signaling depending on the trigger and the consecutive activation of PI3-kinase isoforms.
In addition, PKC inhibition partly prevented the inotropic response to IGF-1 in the present study, and PKC activation occurred downstream from PI3-kinase activation in mammalian myocardium. 36 However, the exact signaling cascade responsible for functional effects of IGF-1 remains to be elucidated. For example, PI3-kinase-dependent Akt activation is a key element in the protection of cardiomyocytes from cell death, 33 but the contribution of Akt to functional effects of IGF-1 is unclear.
Influence of IGF-1 on Intracellular Ca 2؉ Handling
The functional responses to IGF-1 were accompanied by an increase in intracellular Ca 2ϩ transients in the present study. An increase in [Ca 2ϩ ] i as the underlying mechanism for the inotropic effect of IGF-1 was also demonstrated in rat myocytes 18, 30 but not in rat whole-heart preparations. 17 The mechanisms involved in the increase in Ca 2ϩ on acute administration of IGF-1 are unknown. Principally, a rise in [Ca 2ϩ ] i may result from cAMP-dependent (eg, ␤-adrenoceptor stimulation) or cAMP-independent mechanisms. 23, 29 The present data strongly suggest that the functional effects of IGF-1 result from cAMP-independent mechanisms for several reasons, as follows: (1) ␤-adrenoceptor stimulation with ISO, but not IGF-1, enhanced relaxation rate and decay of the Ca 2ϩ transients; (2) IGF-1 increased force and aequorin light emission similar to [Ca 2ϩ ] o , whereas the increase in aequorin light emission was much more pronounced with ISO; and (3) cAMP levels in isolated human myocardium did not change with IGF-1 but were largely increased with ISO.
Inotropic compounds may also directly modulate the responsiveness of the myofilaments for Ca 2ϩ . Previous reports on the effects of IGF-1 on myofilament Ca 2ϩ sensitivity in mammalian myocardium are contradictory. Cittadini et al 17 reported an IGF-1-dependent increase in myofilament Ca 2ϩ sensitivity, but Kinugawa et al 18 could not detect changes in the myofilament responsiveness in rat myocytes. A Ca 2ϩ -sensitizing mode of action typically results in little or no increase in intracellular Ca 2ϩ transients, prolonged relaxation, and diastolic dysfunction. 23, 29 Given that Ca 2ϩ transients increased, and relaxation time as well as diastolic function remained unchanged in the present study, sensitization of the myofilaments does not appear to be a major mode of action of IGF-1 in human myocardium.
We extended the study of intracellular Ca 2ϩ handling and assessed the effects of IGF-1 on SR function and Ca 2ϩ content. RCCs revealed that the inotropic response to IGF-1 was associated with increased SR Ca 2ϩ content. However, pharmacological blockade of SR function did not prevent the inotropic response to IGF-1. Therefore, the increase in SR 24 This is supported by a recent study in rat smooth muscle cells in which IGF-1 increased [Ca 2ϩ ] i through activation of Na ϩ -H ϩ exchange. 25 Taken together, in myocardium from failing human hearts, the functional effects of IGF-1 are mediated by PI3-kinasedependent increases in intracellular Ca 2ϩ transients. The data indicate that IGF-1-induced activation of L-type Ca 2ϩ channels, as well as Na ϩ -H ϩ exchange, followed by enhanced reverse-mode Na ϩ -Ca 2ϩ exchange, contributes to the increase in force and [Ca 2ϩ ] i . Neither increases in cAMP nor altered Ca 2ϩ responsiveness of the myofilaments appears to contribute significantly to the acute inotropic responses to IGF-1. Our data indicate that the potential pathophysiological and clinical relevance of IGF-1-dependent signaling in human heart failure deserves further investigation.
Limitations of the Study
One limitation of the study is that isolated muscle strip preparations produce less contractile force than could be expected from the undamaged, intact organ. However, the basal developed force of the muscles used in this study (22Ϯ2 mN/mm 2 ) is comparable or even higher as reported in previous studies using failing human myocardium. 19, 20, 38 Nevertheless, muscle strips may undergo damage during transport and preparation, and this may affect the results. A further limitation of the study is that aequorin light signals have not been converted to [Ca 2ϩ ] i . This in itself is not a problem, but it largely precludes direct comparison between different inotropic interventions. Although validated for human cardiac muscle, 20 rapid cooling may not release all Ca 2ϩ stored within the SR. 39 In addition, RCCs are an indirect measure of SR Ca 2ϩ content, and subcellular changes, such as a potential IGF-1-induced increase in myofilament responsiveness to Ca 2ϩ , may also result in increased RCCs. The postulated IGF-1-dependent activation of Na ϩ -H ϩ exchange could result in increased pH i resulting in enhanced myofilament Ca 2ϩ responsiveness. However, changes in pH i are unlikely to occur in the presence of bicarbonate-containing physiological buffer solutions 40 and could not be detected in preliminary (nϭ3) experiments using BCECF in human preparations. Furthermore, pharmacological blockade of Na ϩ -H ϩ exchanger 1 and, more likely, reverse-mode Na ϩ -Ca 2ϩ exchange may not be fully specific. 41, 42 Therefore, these experiments indicate, but do not prove, involvement of sodium-dependent exchangers in the inotropic response to IGF-1.
